Table 1.
Pre-partum (3rd trimester of pregnancy) hematological, biochemical and virological characteristics of chronic hepatitis B virus-infected patients
| Overall population | No-reactivation | HBV-reactivation | P value | |
| Patients, n | 27 | 19 | 8 | |
| Hct | 35.9% ± 4.0% | 35.1% ± 3.0% | 37.8% ± 5.6% | 0.312 |
| Hb, g/dL | 12.0 ± 1.4 | 11.6 ± 1.1 | 12.7 ± 1.8 | 0.207 |
| WBC, n | 8.677 ± 2.835 | 8.835 ± 3.122 | 8.308 ± 2.231 | 0.444 |
| PNL | 67.3% ± 10.3% | 68.8% ± 11.0% | 62.3% ± 6.2% | 0.008 |
| LYMPHO | 24.3% ± 9.1% | 23.1% ± 9.8% | 28.5% ± 5.2% | 0.035 |
| MONO | 5.9% ± 1.8% | 5.6% ± 1.9% | 6.8% ± 1.0% | 0.192 |
| PLT, /103 | 209 ± 41 | 212 ± 45 | 202 ± 31 | 0.968 |
| AST, IU/L | 27.6 ± 14.7 | 23.8 ± 6.9 | 35.3 ± 22.8 | 0.585 |
| ALT, IU/L | 30.6 ± 28.2 | 22.2 ± 13.0 | 47.3 ± 42.4 | 0.094 |
| GGT, IU/L | 12.8 ± 6.8 | 14.2 ± 7.2 | 9.8 ± 5.4 | 0.210 |
| LDH, IU/L | 203.8 ± 85.6 | 180.6 ± 79.5 | 250.2 ± 88.8 | 0.214 |
| TBIL, mg/dL | 0.51 ± 0.29 | 0.53 ± 0.34 | 0.47 ± 0.19 | 1.000 |
| DBIL, mg/dL | 0.22 ± 0.20 | 0.26 ± 0.24 | 0.15 ± 0.06 | 0.462 |
| TPROT, g/dL | 6.67 ± 0.58 | 6.84 ± 0.48 | 6.23 ± 0.66 | 0.138 |
| ALB, g/dL | 3.59 ± 0.39 | 3.71 ± 0.32 | 3.25 ± 0.39 | 0.078 |
| GLOB, g/dL | 3.07 ± 0.39 | 3.10 ± 0.42 | 2.97 ± 0.34 | 0.661 |
| HBV DNA ≥ 10000 IU/mL, n (%) | 6 (22.2) | 1 (5.2) | 5 (62.5) | 0.004 |
HBV: Hepatitis B virus; Hct: Hematocrit; Hb: Hemoglobin; WBC: White blood cells; PNL: Polynuclear cells; LYMPHO: Lymphocytes; MONO: Monocytes; PLT: Platelets; AST: Aspartate transaminase; ALT: Alanine transaminase; GGT: Gamma-glutamate transpeptidase; LDH: Lactate dehydrogenase; TBIL: Total bilirubin; DBIL: Direct bilirubin; TPROT: Total protein; ALB: Albumin; GLOB: Globulins.